These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3895662)

  • 21. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
    Yee GC; Self SG; McGuire TR; Carlin J; Sanders JE; Deeg HJ
    N Engl J Med; 1988 Jul; 319(2):65-70. PubMed ID: 3288872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial.
    Morales JM; Andrés A; Prieto C; Ortuño B; Estenoz J; Dorado C; Arenas J; Ruilope LM; Fernández-Cruz L; Rodicio JL
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1537-9. PubMed ID: 2652496
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictors of severe renal dysfunction after heart transplantation and intravenous cyclosporine therapy.
    Macris MP; Ford EG; Van Buren CT; Frazier OH
    J Heart Transplant; 1989; 8(6):444-8; discussion 449. PubMed ID: 2614544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients.
    Textor SC; Forman SJ; Bravo EL; Carlson J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):480-6. PubMed ID: 3291284
    [No Abstract]   [Full Text] [Related]  

  • 26. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
    Britton K; Atkinson K; Downs K; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of cyclosporine with poor initial renal function results in severely diminished renal clearance up to three years following liver transplantation.
    Cooper JL; Wahlstrom E; Anderson J; Schwerman L; Poterucha J; Krom RA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1489-91. PubMed ID: 1989274
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term effects of cyclosporine on renal function in organ transplant recipients.
    Bantle JP; Paller MS; Boudreau RJ; Olivari MT; Ferris TF
    J Lab Clin Med; 1990 Feb; 115(2):233-40. PubMed ID: 2405085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal function studies in cyclosporine-treated non-kidney transplant recipients of pancreas grafts.
    De Francisco AM; Casanova D; Sutherland DE; Mauer SM; Steffes MW; Goetz FC; Najarian JS
    Transplant Proc; 1987 Oct; 19(5):3995-7. PubMed ID: 3313981
    [No Abstract]   [Full Text] [Related]  

  • 30. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
    Cohen SL; Boner G; Rosenfeld JB; Shmueli D; Sperling O; Yusim A; Todd-Pokropek A; Shapira Z
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
    [No Abstract]   [Full Text] [Related]  

  • 31. Mismatched living, related donor renal transplantation: a prospective, randomized study.
    Sommer BG; Ferguson RM
    Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 33. [New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
    Hosen N; Teshima H; Karasuno T; Ujiie H; Nakao T; Yagi T; Hatanaka K; Kawamoto S; Hiraoka A; Nakamura H; Masaoka T
    Rinsho Ketsueki; 1999 Jan; 40(1):9-15. PubMed ID: 10067090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
    Truog AW; Wozniak SP
    Oncol Nurs Forum; 1990; 17(1):39-44. PubMed ID: 2405360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
    Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
    Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
    Ringdén O; Bäckman L; Lönnqvist B; Heimdahl A; Lindholm A; Bolme P; Gahrton G
    Bone Marrow Transplant; 1986 May; 1(1):41-51. PubMed ID: 3332119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantation.
    Pichlmayr R; Wonigeit K; Ringe B; Block T; Raab R; Heigel B; Neuhaus P
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():947-60. PubMed ID: 3887390
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of cyclosporine A on long-term renal function in pediatric liver transplant recipients.
    Andrews WA; Arant BS; Fyock B; Gray S; Schlatter MG; Conlin C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1452-3. PubMed ID: 1989261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.